Kinase activity and phosphorylation assays

• Protein kinases catalyze transfer of the terminal phosphate of ATP to defined amino-acid residues in protein or peptide substrates. Kinase activity can therefore be measured directly by quantifying phosphate incorporation into a substrate or indirectly by quantifying ADP generated during the reaction^[1][2][3].

• In the radiometric assay, a kinase reaction is performed with ATP containing a γ-phosphate labeled with ^32P. Transfer of the γ-phosphate to a protein or peptide substrate produces a radiolabeled substrate that can be separated from unreacted nucleotide and quantified by scintillation counting or phosphorimaging; the resulting signal reflects catalytic phosphate transfer during the reaction^[1].

• In the luminescent ADP assay, the kinase reaction generates ADP in proportion to substrate phosphorylation. After the kinase reaction, residual ATP is depleted, ADP is converted back to ATP, and a luciferase reaction produces luminescence proportional to the amount of ADP generated; this method measures the direct nucleotide product of the kinase reaction and has produced results comparable with radiometric assays across multiple protein kinases^[2][3].

• Phosphorylation-state assays detect the phosphorylated form of a defined protein rather than measuring nucleotide turnover. A phosphospecific cell-based ELISA uses antibodies selective for phosphorylated epitopes to provide a semiquantitative measure of signaling-protein phosphorylation in fixed cells, whereas phosphospecific immunoblotting resolves proteins by electrophoresis before antibody detection and can verify that the signal occurs at the expected molecular mass^[4][5].

• The protocol below therefore contains two complementary modules: an in-vitro kinase-activity module using either radiometric phosphate incorporation or luminescent ADP detection, and a cell-based phosphorylation module using phosphospecific immunodetection. Activity and phosphorylation results should not be treated as interchangeable because a phosphorylation signal reports the abundance of a selected phospho-epitope, whereas the activity assays report catalytic phosphate transfer or ADP formation under the defined in-vitro conditions^[1][2][4][5].

Reagents and chemicals

• Purified recombinant kinase, or kinase isolated by immunoprecipitation, provides the catalytic enzyme for the in-vitro reaction^[1].

• A validated protein or peptide substrate provides the phosphate acceptor for the target kinase^[1][3].

• Unlabeled ATP provides the phosphoryl donor and is required in both radiometric and luminescent kinase reactions^[1][2].

• ^{[γ-^32P]}ATP provides a radiolabeled terminal phosphate for direct measurement of phosphate transfer in the radiometric assay^[1].

• A kinase-compatible reaction buffer containing the cofactors required by the selected kinase supports enzymatic activity; buffer composition must be selected from a published assay for the kinase under investigation rather than assumed to be universal^[1][3].

• Phosphoric-acid wash solution removes unincorporated radiolabeled ATP from phosphocellulose paper when a basic peptide substrate is used^[1].

• Cell-culture medium, serum and the kinase-pathway stimulus or inhibitor are required for the cell-based phosphorylation experiment; stimulation conditions must be defined for the selected pathway and cell model^[4].

• Paraformaldehyde is used to fix cells while preserving phosphorylation-dependent antibody reactivity in the cell-based ELISA^[4].

• A detergent-containing buffer permeabilizes fixed cells and permits antibody access to intracellular phosphoproteins^[4].

• A protein-containing blocking solution reduces nonspecific antibody binding during phosphospecific immunodetection^[4][5].

• SDS sample buffer, electrophoresis buffer, transfer buffer and washing buffer are required when phosphorylation is assessed by immunoblotting^[5].

Antibodies, probes, dyes, or kits

• A site-specific phospho-antibody detects the phosphorylated residue or activation-loop epitope of the selected target protein^[4][5].

• An antibody against the corresponding total protein permits normalization of phospho-signal to target-protein abundance^[5].

• An antibody against a stable loading-control protein can be used to evaluate sample loading in immunoblot experiments^[5].

• An enzyme-conjugated secondary antibody and compatible chromogenic or chemiluminescent substrate generate the cell-based ELISA or immunoblot readout^[4][5].

• Crystal violet provides a cell-number normalization measurement in the phosphospecific cell-based ELISA described by Versteeg and colleagues^[4].

• ADP-detection reagents comprising an ATP-depletion step, an ADP-to-ATP conversion step and a luciferase-based detection system generate luminescence proportional to kinase-produced ADP^[2][3].

Equipment and instruments

• A calibrated pipette set is required for preparation of small-volume kinase reactions^[1][2].

• A temperature-controlled incubator or heating block maintains the reaction temperature used in the selected published kinase assay^[1].

• A scintillation counter or phosphorimager quantifies radiolabeled phosphorylated substrate^[1].

• A white multiwell plate and luminescence-compatible microplate reader are used for ADP-based kinase detection^[2][3].

• A cell-culture incubator and tissue-culture plates are required for pathway-stimulation and cell-based phosphorylation experiments^[4].

• An absorbance microplate reader measures chromogenic phosphospecific ELISA and cell-normalization signals^[4].

• Electrophoresis, protein-transfer and chemiluminescence-imaging systems are required for phosphospecific immunoblotting^[5].

Preparation Steps

A. Experimental design

• Select a kinase, a substrate whose phosphorylation by that kinase has been demonstrated, and a published reaction buffer appropriate for that enzyme–substrate pair. Establish kinase-minus and substrate-minus reactions, and include an inactive kinase, a kinase-dead mutant or a validated inhibitor when one of these controls is available in the selected biological system^[1][3].

• For inhibitor studies, include a vehicle-treated active-kinase control, a no-kinase background control and the tested inhibitor concentrations. Keep the solvent concentration constant across compared reactions because the purpose of the vehicle control is to isolate the effect of the candidate inhibitor from the effect of its solvent^[3].

B. Kinase and substrate preparation

• Prepare the kinase and substrate in the reaction buffer immediately before use and maintain protein samples under the storage conditions validated for those proteins. Determine an enzyme amount and reaction duration that yield a signal within the initial, approximately linear phase of product formation; activity measurements made after extensive substrate consumption or ATP depletion do not provide an initial-rate measurement^[2][3].

• When the kinase is obtained by immunoprecipitation, prepare matched immunoprecipitates from experimental and control samples, wash the immune complexes to remove soluble cellular ATP and nonspecifically associated material, and retain a fraction for immunoblot analysis of recovered kinase abundance. Comparison of catalytic signals without assessing kinase recovery can confound changes in enzyme quantity with changes in specific activity^[1].

C. Radiometric reagent preparation

• Prepare a working ATP mixture containing unlabeled ATP and^{[γ-^32P]}ATP at the ATP concentration defined for the selected kinase assay. Handle ^32P only under institutionally approved radiation procedures, including authorized work areas, shielding, contamination monitoring and regulated radioactive-waste disposal^[1].

• Pre-label phosphocellulose papers and prepare sufficient phosphoric-acid wash solution before starting the reaction. The phosphocellulose-paper format is appropriate when the phosphorylated substrate is retained by the paper under the reported acidic washing conditions; alternative substrate-separation methods are required when the substrate is not retained efficiently^[1].

D. Luminescent ADP-assay preparation

• Prepare an ATP-to-ADP standard curve in the same ATP concentration and reaction matrix used for the kinase reactions. The standard curve permits conversion of relative luminescence into the amount or percentage of ATP converted to ADP and controls for matrix-dependent effects on nucleotide detection^[2].

• Equilibrate the kinase-reaction and ADP-detection reagents according to the conditions validated in the published assay, and use identical reaction volumes and detection-reagent ratios across the plate. Because luminescence reports ADP from any ADP-producing process in the well, the no-kinase and substrate-minus controls are required to quantify nucleotide background unrelated to target-dependent phosphorylation^[2][3].
E. Cell preparation for phosphorylation analysis

• Seed cells in multiwell plates at a density that produces a reproducible cell layer at the time of stimulation. Apply the pathway stimulus, inhibitor or vehicle for the concentration and duration established in a peer-reviewed study for the selected cell type and phosphorylation target; a universal stimulation condition should not be substituted across pathways^[4].

• Include unstimulated cells as a basal-phosphorylation control, stimulated cells as a response control and, when available, stimulated cells treated with a mechanistically validated pathway inhibitor as a specificity control. Prepare parallel wells for phosphospecific detection and cell-number normalization^[4].

Operation Steps

A. Radiometric kinase-activity assay

• Assemble kinase, substrate and reaction-buffer components without ATP. • Prepare sufficient master mixture to reduce pipetting variation, while keeping kinase-minus and substrate-minus controls compositionally matched to the complete reaction^[1].

• Initiate the reaction by adding the ATP/^{[γ-^32P]}ATP mixture. Mix without introducing excessive bubbles and incubate at the temperature and for the duration established for the selected kinase–substrate system; Karra and colleagues describe 30 °C as the reaction temperature in their representative radiometric kinase procedure^[1].

• At the selected endpoint, apply an aliquot of each reaction to phosphocellulose paper to terminate and capture the phosphorylated basic peptide substrate. Allow the spotted papers to dry before washing^[1].

• Wash the papers repeatedly in 0.75% phosphoric acid to remove unreacted^{[γ-^32P]}ATP. Karra and colleagues describe three phosphoric-acid washes of 5 minutes each, followed by an acetone wash to promote drying^[1].

• Dry the washed papers, place each paper in scintillation fluid and measure radioactivity by scintillation counting. Alternatively, quantify dried radioactive samples with an appropriately calibrated phosphorimaging workflow when that detection format has been validated^[1].

• Subtract the kinase-minus background from each complete reaction. Where the ATP specific activity and counting efficiency are known, convert background-corrected counts into moles of phosphate transferred and express activity relative to reaction time and kinase amount^[1].

B. Luminescent ADP-based kinase-activity assay

• Dispense kinase, substrate, ATP and reaction buffer into a white microplate. Include kinase-minus, substrate-minus, complete active-kinase, vehicle and inhibitor-treated reactions as applicable^[2][3].

• Initiate reactions by adding ATP or kinase consistently across the plate and incubate under conditions demonstrated to maintain measurable product formation without excessive ATP conversion. Optimize enzyme amount and reaction time by testing multiple enzyme concentrations or time points before using the assay for comparative measurements^[2][3].

• Add the ATP-depletion reagent to stop kinase activity and remove ATP remaining after the reaction. The ADP-detection method requires this depletion step because residual ATP would otherwise contribute directly to the luciferase signal^[2].

• Add the reagent that terminates ATP depletion, converts ADP to ATP and supplies the luciferase detection chemistry. Allow signal development under the incubation conditions reported for the selected assay implementation and read luminescence with constant reader settings for all compared wells^[2][3].

• Use the ATP-to-ADP standard curve to calculate ADP produced or percentage substrate conversion. Subtract the no-kinase background before comparing activities, and restrict quantitative comparisons to the standard-curve and instrument-response ranges in which luminescence remains proportional to ADP^[2].

C. Phosphospecific cell-based ELISA

• At the end of stimulation, remove the culture medium and fix the cells in the plate. The original phosphospecific cell-based ELISA used formaldehyde-based fixation to preserve the cells and permit subsequent antibody detection^[4].

• Wash the fixed cells, permeabilize them with a detergent-containing buffer and block nonspecific antibody-binding sites with a protein-containing blocking solution^[4].

• Incubate the cells with a phosphospecific primary antibody validated for the selected target and phosphorylation site. In matched wells, omit the primary antibody to measure secondary-antibody and substrate background^[4].

• Wash the wells and incubate with the appropriate enzyme-conjugated secondary antibody. Remove unbound antibody by repeated washing before adding the enzyme substrate^[4].

• Add the chromogenic substrate, allow color development for a constant interval across the plate, stop the reaction and measure absorbance at the wavelength appropriate for the selected substrate. Versteeg and colleagues used o-phenylenediamine detection and measured the reaction product at 490 nm^[4].

• After phospho-signal measurement, use matched wells or a compatible sequential procedure to stain cells with crystal violet and measure cell-associated dye. Normalize the phosphospecific signal to the cell-number signal to reduce variation caused by differences in cell density or cell loss^[4].

D. Phosphospecific immunoblot confirmation

• Lyse matched stimulated and control samples under conditions that preserve phosphorylation, determine protein concentration and load equal amounts of total protein for SDS-PAGE^[5].

• Transfer separated proteins to a membrane, block the membrane and incubate it with the phosphospecific primary antibody followed by an appropriate labeled secondary antibody^[5].

• Detect the phosphoprotein signal and confirm that the principal immunoreactive band occurs at the expected molecular mass. Reprobe the membrane or analyze a matched membrane with an antibody against total target protein^[5].

• Quantify phosphoprotein and total-protein bands within the nonsaturated range of the imaging system. Express phosphorylation as the phosphoprotein signal divided by the corresponding total-target signal, with the same background-subtraction rule applied to all samples^[5].

Data Acquisition and Analysis

• For radiometric assays, calculate the mean background from kinase-minus reactions and subtract it from complete reactions. When sufficient calibration information is available, convert counts per minute into phosphate transferred and report activity per unit time and enzyme amount; otherwise report background-corrected counts under explicitly stated reaction conditions^[1].

• For luminescent assays, interpolate each sample from the ATP-to-ADP standard curve and calculate ADP generated or percentage ATP conversion. A kinase inhibitor decreases ADP-dependent luminescence relative to the vehicle-treated active-kinase control, whereas loss of signal in both complete and control wells indicates a detection or reagent problem rather than selective kinase inhibition^[2][3].

• For phosphospecific cell-based ELISA, subtract the no-primary-antibody background and normalize the resulting phosphospecific absorbance to the crystal-violet cell signal. Report the normalized value relative to the unstimulated or vehicle control, and verify selected findings by phosphospecific immunoblotting because electrophoretic separation tests whether antibody reactivity occurs at the expected target-protein size^[4][5].

• For phosphospecific immunoblots, calculate the phosphoprotein-to-total-protein ratio for each sample. This ratio distinguishes altered phosphorylation stoichiometry from changes in total target abundance more effectively than phosphoprotein signal alone^[5].

• Use independent biological samples for biological inference and use technical replicate wells to evaluate within-assay precision. Do not treat technical wells prepared from the same biological sample as independent biological replicates. Report the number of independent experiments, the definition of each replicate, the summary statistic, variability measure and statistical test used^[2][3].

• For plate-based assays intended for screening, evaluate separation between positive and negative controls across the plate. The Z′ factor incorporates the means and standard deviations of the positive and negative controls, and values between 0.5 and 1 were defined by Zhang and colleagues as indicating an excellent assay window for high-throughput screening^[6].

• Interpret kinase activity together with phosphorylation controls. Increased substrate phosphorylation, radiolabeled phosphate incorporation or ADP formation supports increased catalytic activity under the assay conditions, but attribution to a specific kinase requires an appropriate kinase-minus, inactive-enzyme, inhibitor or genetic control^[1][3][4].

Problem: High radiometric signal in the kinase-minus control.

Possible Cause:
Unincorporated^{[γ-^32P]}ATP was not removed completely, or the substrate preparation contains an unintended kinase or ATP-binding contaminant.
Literature-supported Solution:
Perform the repeated 0.75% phosphoric-acid washes described for phosphocellulose-paper assays and compare kinase-minus, substrate-minus and complete reactions to localize the source of the signal. Use purified substrate or an alternative substrate-separation method when the background remains substrate-associated^[1].

Problem: Radiometric activity is weak despite detectable kinase protein.

Possible Cause:
The reaction is outside the effective range for kinase amount, substrate concentration, ATP concentration or incubation time, or the chosen substrate is not efficiently retained by phosphocellulose paper.
Literature-supported Solution:
Establish activity over a kinase-concentration or time series and verify substrate capture independently; use a different separation method when the phosphorylated substrate does not bind phosphocellulose efficiently^[1].

Problem: Luminescence is high in no-kinase wells.

Possible Cause:
The reaction mixture contains pre-existing ADP, an additional ADP-producing enzyme or nucleotide contamination.
Literature-supported Solution:
Measure kinase-minus and substrate-minus controls in the complete reaction matrix, subtract the experimentally measured background and prepare fresh ATP and reaction components when background compromises the usable signal window^[2][3].

Problem: Luminescent signal does not increase with kinase concentration or reaction time.

Possible Cause:
The reaction has reached substantial ATP conversion, the substrate has become limiting or the luminescence response is outside its proportional range.
Literature-supported Solution:
Reduce kinase amount or incubation time, generate an ATP-to-ADP standard curve in the assay matrix and select conditions that produce a signal within the proportional region of the nucleotide-detection response^[2][3].

Problem: A compound suppresses the luminescent signal but not the radiometric assay.

Possible Cause:
The compound may interfere with ADP conversion, luciferase activity or light production rather than inhibiting the kinase.
Literature-supported Solution:
Test the compound against an ATP-to-ADP standard without kinase and confirm activity with an orthogonal radiometric phosphate-transfer assay^[1][3].

Problem: Cell-based phosphospecific ELISA signal varies with cell density.

Possible Cause:
Differences in cell number, attachment or loss during washing alter the total antigen-bearing material in each well.
Literature-supported Solution:
Normalize phosphospecific absorbance to crystal-violet staining and exclude conditions producing extensive cell loss when the objective is to compare phosphorylation per retained cell population^[4].

Problem: Phosphospecific ELISA gives a response that cannot be assigned confidently to the intended protein.

Possible Cause:
The phosphospecific antibody may recognize additional phosphorylation-dependent cellular proteins because the plate assay does not separate proteins by molecular mass.
Literature-supported Solution:
Analyze matched samples by phosphospecific immunoblotting and require a treatment-responsive band at the expected molecular mass before assigning the cell-based signal to the target protein^[4][5].

Problem: Phosphoprotein signal changes while total target-protein abundance also changes.

Possible Cause:
The phospho-signal difference may reflect altered target abundance rather than a change in the fraction of phosphorylated protein.
Literature-supported Solution:
Quantify both phosphoprotein and total target protein and compare the phosphoprotein-to-total-protein ratio across samples^[5].